ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma
Clinical trial NCT02757326 · TERMINATED
Trial details
- NCT number
- NCT02757326
- Sponsor
- RedHill Biopharma Limited
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-13
- Primary completion
- 2019-05-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.